ReviewMedicina (Kaunas, Lithuania)2026
Early-Life Oxidative Stress and Pediatric Kidney Disease: From Developmental Programming to Preventive Strategies.
Review in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The first 1000 days of life represent a critical window for renal development and long-term kidney health. During this period, oxidative stress and mitochondrial dysfunction may disrupt nephrogenesis, renal maturation, and redox-sensitive developmental pathways, potentially contributing to reduced nephron endowment and greater susceptibility to hypertension and chronic kidney disease later in life. This narrative review examines prenatal, perinatal, and early postnatal factors that may contribute to oxidative renal injury, including maternal metabolic and nutritional conditions, prematurity, impaired fetal growth, perinatal interventions, early-life nutritional and inflammatory factors, and environmental exposures. Particular attention is given to the concept of renal vulnerability and to the distinction between clinical evidence of long-term kidney risk and experimental evidence supporting potential mechanisms of developmental renal programming. Clinical cohort data indicate an increased risk of kidney disease later in life following prematurity and impaired fetal growth, although these associations do not establish oxidative stress as a causal mediator. We also discuss preventive and emerging reprogramming strategies. While mitochondrial-targeted, nutritional, and antioxidant approaches remain promising, current evidence is predominantly preclinical and does not support routine antioxidant supplementation or screening for oxidative stress biomarkers in children. From a practical pediatric perspective, early identification of relevant risk factors, appropriate clinical assessment, optimization of modifiable exposures, and individualized referral to pediatric nephrology represent the most clinically relevant strategies for protecting long-term kidney health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.